Editor, Jade Parker recently spoke with David Adams, Wellcome Trust Sanger Institute (Cambridge, UK) about utilizing DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions.
Browsing: Disease Area > Skin
In this infographic gain a visual snapshot of a review article in which over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.
In this editorial, we will review emerging evidence for the relationship between sexual orientation, indoor tanning and melanoma and discuss implications for clinical practice, research and public health.
This editorial discusses the impact of the numer of melanocytic nevi (moles) and the risk of developing melanoma.
This article provides a immunotherapy perspective of Ipilimumab, a CTLA-4-targeted monoclonal antibody, reviewing drug mechanism, blockade, combination therapies and future prospectives.
A group of researchers from the University of Missouri (MO, USA) report a novel technique for detecting and analyzing melanoma cells which could lead to better and faster diagnosis of the disease.
Discuss the history of the development of intralesional therapies, current effective therapies and the future direction of these injectable therapies.
A group of researchers may have improved the efficacy of cancer immunotherapy by blocking two proteins that regulate the growth of tumor blood vessels.
In this editorial from Melanoma Management the authors examine melanoma clinical trials with a focus upon targeted therapies and melanoma vaccines.
In this review article, over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.